MedPath

Valsartan-Hydroflumethiazide

Generic Name
Valsartan-Hydroflumethiazide

Overview

No overview information available.

Background

No background information available.

Indication

用于治疗单一药物不能充分控制血压的轻至中度原发性高血压。本品不适用于高血压的初始治疗。

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor

No clinical trials found

No clinical trials found for this drug

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Valsartan and Hydrochlorothiazide Dispersible Tablets
国药准字H20090262
化学药品
片剂
12/25/2023
Valsartan and Hydrochlorothiazide Dispersible Tablets
国药准字H20090282
化学药品
片剂
5/25/2023
Valsartan and Hydrochlorothiazide Dispersible Tablets
国药准字H20110092
化学药品
片剂
12/23/2020
Valsartan and Hydrochlorothiazide Tablets
国药准字H20213285
化学药品
片剂
4/13/2021
Valsartan and Hydrochlorothiazide Tablets
国药准字H20070118
化学药品
片剂
4/22/2022
Valsartan and Hydrochlorothiazide Tablets
国药准字HJ20181070
化学药品
片剂
5/6/2022
Valsartan and Hydrochlorothiazide Tablets
国药准字H20203024
化学药品
片剂
2/11/2020
Valsartan and Hydrochlorothiazide Tablets
国药准字H20233071
化学药品
片剂
1/19/2023
Valsartan and Hydrochlorothiazide Tablets
国药准字H20223460
化学药品
片剂
6/30/2022
Valsartan and Hydrochlorothiazide Tablets
国药准字H20249169
化学药品
片剂
10/22/2024

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.
© Copyright 2025. All Rights Reserved by MedPath